• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异黄酮阴道凝胶有效治疗阴道萎缩

Effective treatment of vaginal atrophy with isoflavone vaginal gel.

作者信息

Lima Sonia M Rolim Rosa, Yamada Silvia Saito, Reis Benedito Fabiano, Postigo Sostenes, Galvão da Silva Maria Antonieta L, Aoki Tsutomu

机构信息

Department of Gynecology and Obstetrics, Santa Casa of Sao Paulo Medical School, Sao Paulo, Brazil.

Department of Gynecology and Obstetrics, Santa Casa of Sao Paulo Medical School, Sao Paulo, Brazil; Department of Gynecology and Obstetrics, Vale do Sapucaí University, Pouso Alegre, Minas Gerais, Brazil.

出版信息

Maturitas. 2013 Mar;74(3):252-8. doi: 10.1016/j.maturitas.2012.11.012. Epub 2013 Jan 9.

DOI:10.1016/j.maturitas.2012.11.012
PMID:23312487
Abstract

OBJECTIVE

To assess efficacy and tolerability of a isoflavone (Glycine max L. Merr.) vaginal gel to the treatment of vaginal atrophy in postmenopausal women.

METHODS

The double-blind, randomized, placebo-controlled, clinical trial. Ninety women were treated for 12 weeks with isoflavone vaginal gel 4% (1g/day) and a placebo gel and conjugated equine estrogen cream (0.3mg/day). After 4 and 12 weeks, the vaginal atrophy symptoms were classified at none, mild, moderate and severe and the vaginal cytology were taken to determine the maturation value. The endometrial safety (by transvaginal ultrasonography) was evaluated through at screening and the end of the trial.

RESULTS

Isoflavone vaginal gel appears to be effective for relief of vaginal dryness and dyspareunia symptoms and an increase in the intermediate and superficial cells was noted. These results were similar to the effects with use of conjugated equine estrogens and superior to placebo gel. No changes in endometrial thickness, sera FSH and estradiol levels were observed at study endpoint.

CONCLUSION

Glycine max (L.) Merr. at 4% vaginal gel on a daily basis in postmenopausal women led to improvements in vaginal atrophy symptoms and a significant increase in cell maturation values. Isoflavones proved good treatment options for relief of vulvovaginal symptoms especially in women who do not wish to use hormonal therapy or have contra-indications for this treatment.

摘要

目的

评估一种异黄酮(大豆)阴道凝胶治疗绝经后妇女阴道萎缩的疗效和耐受性。

方法

双盲、随机、安慰剂对照临床试验。90名女性分别接受4%异黄酮阴道凝胶(1克/天)、安慰剂凝胶和结合马雌激素乳膏(0.3毫克/天)治疗12周。在4周和12周后,将阴道萎缩症状分为无、轻度、中度和重度,并进行阴道细胞学检查以确定成熟值。通过经阴道超声在筛查时和试验结束时评估子宫内膜安全性。

结果

异黄酮阴道凝胶似乎对缓解阴道干燥和性交困难症状有效,且观察到中层和表层细胞增加。这些结果与使用结合马雌激素的效果相似,且优于安慰剂凝胶。在研究终点未观察到子宫内膜厚度、血清促卵泡生成素和雌二醇水平的变化。

结论

绝经后妇女每天使用4%大豆阴道凝胶可改善阴道萎缩症状,并显著提高细胞成熟值。异黄酮被证明是缓解外阴阴道症状的良好治疗选择,尤其是对于那些不希望使用激素疗法或有该治疗禁忌症的女性。

相似文献

1
Effective treatment of vaginal atrophy with isoflavone vaginal gel.异黄酮阴道凝胶有效治疗阴道萎缩
Maturitas. 2013 Mar;74(3):252-8. doi: 10.1016/j.maturitas.2012.11.012. Epub 2013 Jan 9.
2
Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.大豆(Glycine max (L.) Merr.)异黄酮阴道凝胶对绝经后女性上皮形态及雌激素受体表达的影响:一项为期12周的随机双盲安慰剂对照试验
Maturitas. 2014 Jul;78(3):205-11. doi: 10.1016/j.maturitas.2014.04.007. Epub 2014 May 6.
3
A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.一项评价雌二醇阴道乳膏 0.003%用于绝经后以阴道干燥为最困扰症状的女性的安全性和有效性的随机、多中心、双盲研究。
J Womens Health (Larchmt). 2018 Mar;27(3):231-237. doi: 10.1089/jwh.2017.6515. Epub 2017 Dec 1.
4
Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.一种新的阴道凝胶治疗绝经后妇女与外阴阴道萎缩相关症状的疗效和安全性:一项双盲随机安慰剂对照研究。
Maturitas. 2021 May;147:34-40. doi: 10.1016/j.maturitas.2021.03.002. Epub 2021 Mar 4.
5
Merr isoflavone gel improves vaginal vascularization in postmenopausal women.美雌醇凝胶能改善绝经后妇女的阴道血管生成。
Climacteric. 2020 Oct;23(5):505-510. doi: 10.1080/13697137.2020.1752172. Epub 2020 Apr 27.
6
Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.一项随机、多中心、双盲、安慰剂对照试验,旨在评估合成共轭雌激素B治疗健康绝经后女性外阴阴道萎缩的疗效和安全性。
Fertil Steril. 2008 Oct;90(4):1132-8. doi: 10.1016/j.fertnstert.2007.07.1359. Epub 2007 Dec 3.
7
Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women.葛根提取物凝胶与结合马雌激素乳膏对绝经后女性阴道健康影响的比较。
Menopause. 2017 Feb;24(2):210-215. doi: 10.1097/GME.0000000000000742.
8
Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy.每周两次使用合成共轭雌激素阴道乳膏治疗阴道萎缩。
Menopause. 2009 Jul-Aug;16(4):735-41. doi: 10.1097/gme.0b013e318199e734.
9
A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.一项随机、多中心、双盲研究,旨在评估0.003%雌二醇阴道乳膏对以性交困难为最困扰症状的绝经后女性的安全性和有效性。
Menopause. 2018 Feb;25(2):133-138. doi: 10.1097/GME.0000000000000985.
10
Hormonal, metabolic, and endometrial safety of testosterone vaginal cream versus estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: a randomized, placebo-controlled study.睾酮阴道乳膏与雌激素治疗绝经后女性外阴阴道萎缩的激素、代谢及子宫内膜安全性:一项随机、安慰剂对照研究
Menopause. 2018 Jun;25(6):641-647. doi: 10.1097/GME.0000000000001059.

引用本文的文献

1
Efficacy and Safety of Intravaginal Estrogen in the Treatment of Atrophic Vaginitis: A Systematic Review and Meta-Analysis.阴道内雌激素治疗萎缩性阴道炎的疗效与安全性:一项系统评价与荟萃分析
J Menopausal Med. 2024 Aug;30(2):88-103. doi: 10.6118/jmm.23037.
2
Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause : A Systematic Review.绝经后女性泌尿生殖系统综合征的激素治疗和阴道保湿剂:系统评价。
Ann Intern Med. 2024 Oct;177(10):1400-1414. doi: 10.7326/ANNALS-24-00610. Epub 2024 Sep 10.
3
Complementary and Alternative Therapies for Genitourinary Syndrome of Menopause : An Evidence Map.
补充和替代疗法治疗绝经后泌尿生殖系统综合征:证据图谱。
Ann Intern Med. 2024 Oct;177(10):1389-1399. doi: 10.7326/ANNALS-24-00603. Epub 2024 Sep 10.
4
Use of Fermented Red Clover Isoflavones in the Treatment of Overactive Bladder in Postmenopausal Women: A Randomized, Double-Blinded, Placebo-Controlled Trial.红车轴草异黄酮治疗绝经后妇女膀胱过度活动症的随机、双盲、安慰剂对照试验。
Nutrients. 2023 Sep 27;15(19):4165. doi: 10.3390/nu15194165.
5
Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis.与目前治疗外阴阴道萎缩的疗法相比,奥昔布宁治疗外阴阴道萎缩的疗效、耐受性和子宫内膜安全性:系统文献回顾和网络荟萃分析。
Menopause. 2023 Aug 1;30(8):855-866. doi: 10.1097/GME.0000000000002211. Epub 2023 Jun 27.
6
Formulation and In Vitro Evaluation of Mucoadhesive Sustained Release Gels of Phytoestrogen Diarylheptanoids from for Vaginal Delivery.用于阴道给药的植物雌激素二芳基庚烷类粘膜粘附缓释凝胶的制剂与体外评价
Pharmaceutics. 2023 Jan 12;15(1):264. doi: 10.3390/pharmaceutics15010264.
7
Phytoestrogens and Health Effects.植物雌激素与健康效应。
Nutrients. 2023 Jan 9;15(2):317. doi: 10.3390/nu15020317.
8
Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review.绝经后女性阴道萎缩和性功能障碍的激素和非激素治疗方法的疗效:系统评价。
Rev Bras Ginecol Obstet. 2022 Oct;44(10):986-994. doi: 10.1055/s-0042-1756148. Epub 2022 Nov 29.
9
Comparison of Severity of Genitourinary Syndrome of Menopause Symptoms After Carbon Dioxide Laser vs Vaginal Estrogen Therapy: A Systematic Review and Meta-analysis.二氧化碳激光与阴道雌激素治疗对绝经后泌尿生殖系统综合征症状严重程度的比较:系统评价和荟萃分析。
JAMA Netw Open. 2022 Sep 1;5(9):e2232563. doi: 10.1001/jamanetworkopen.2022.32563.
10
An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy.一项关于VagiVital用于接受辅助芳香化酶抑制剂治疗的乳腺癌患者外阴阴道萎缩治疗12周的开放性、非对照性试点研究。
Med Devices (Auckl). 2021 Jun 25;14:193-200. doi: 10.2147/MDER.S303234. eCollection 2021.